Chemotherapy trial in paucibacillary leprosy using clofazimine

Indian Journal of Leprosy

Volumn 71, Issue 3, 1999, Pages 311-324

  Katoch, K ^a   Natarajan, M ^a   Katoch, V M ^a   Singh, H B ^a   Bhatia, A S ^b  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; RIFAMPICIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LEPROMIN TEST; LEPROSY; LEPROSY EPIDEMIOLOGY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; RANDOMIZED CONTROLLED TRIAL; SKIN COLOR;

CLOFAZIMINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEPROSTATIC AGENTS; LEPROSY, BORDERLINE; LEPROSY, TUBERCULOID; MALE;

EID: 0033428432     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bhate RD, Gupta CM, Chattopadhyay SP, Singh IP 1986. Experience with multidrug therapy in paucibacillary leprosy. Indian J Lepr 58: 244-250.
2. Becx-Bleumink M, Berhe D 1992. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Centre (ALERT) in Ethiopia. Int J Lepr 60: 173-184.
3. Becx-Bleumink M 1992. Relapses among leprosy patients treated with multidrug therapy. Experience in the leprosy control programme of the All Africa Leprosy and Rehabilitation Centre (ALERT) Ethiopia: Practical difficulties with diagnosis of relapses, operational procedures and criteria for diagnosing relapses. Int J Lepr 60: 421-435.
4. Boerrigter G, Pönnighaus JM, Fine PEM, Wilson RJ 1991. Four year follow-up result of a WHO recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi. Int J Lepr 59: 255-261.
5. Dasananjali K, Schreuder M, Pirayavaroporn C 1997. A study on the effectiveness and safety of WHO/MDT regimen in Northeast Thailand: a prospective study, 1984-1996. Int J Lepr 65: 28-36.
6. Dhir R, Guha PK, Singh G 1986. Short term chemotherapy of paucibacillary leprosy. Indian J Lepr 58: 549-554.
7. Grugni A, Nadkarni NJ, Kini MS, Mehta VR 1990. Relapses in paucibacillary leprosy after MDT - A clinical study. Int J Lepr 58: 19-24.
8. Kar PK, Jha PK, Panayach JS, Snehi PS 1988. A clinico-pathological study of multidrug regimen in paucibacillary leprosy. Indian J Lepr 60: 235-241.
9. Katoch K, Ramu G, Ramanathan U 1985. Comparison of three regimens containing rifampicin for the treatment of paucibacillary leprosy patients; a preliminary report. Indian J Lepr 57: 499-506.
10. Katoch K, Ramu G, Ramanthan U, Desikan KV 1987. Comparison of three regimens containing rifampicin for the treatment of paucibacillary leprosy patients. Int J Lepr 55: 1-8.
11. Katoch K, Ramanathan U, Natarajan M et al 1989. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin. Int J Lepr 57: 458-464.
12. Katoch VM, Kanaujia GV, Shivannavar CT et al 1992. rRNA gene-based probes for early diagnosis and epidemiology of leprosy. Quaderni di co-operazione sanitaria - Health cooperation papers 12: 163-166.
13. Katoch VM, Kanaujia GV, Shivannavar CT et al 1994. Progress in developing ribosomal RNA and rRNA gene(s)-based probes for diagnosis and epidemiology of infectious diseases specially leprosy. In: Tropical disease - Molecular Biology & Control Strategy, eds Sushil Kumar, AK Sen, GP Dutta, RN Sharma. A CSIR publication, 580-587.
14. Kaur S, Sharma VK, Bhushan Kumar, Kaur I 1984. Experience with two-drug regimen in paucibacillary leprosy: a preliminary report. Indian J Lepr 56: 48-49.
15. Li HY, Fu LF, Huang WB et al 1997. Risk of relapse in leprosy after fixed duration multidrug therapy. Int J Lepr 65: 238-245.
16. Orege PA, Obura M, Okelo C et al 1989. Multidrug therapy for treatment of paucibacillary leprosy. The western Kenya experience. Int J Lepr 57: Suppl 1: 341.
17. Pavithran K 1988. Relapses of paucibacillary leprosy after short course multidrug therapy. Indian J Lepr 60: 225-229.
18. Rangaraj M, Rangaraj J 1986. Experience with MDT in Sierra Leone; clinical, operational and managerial analysis. Lepr Rev 57: Suppl 3: 77-91.
19. Revankar CR, Karjivkar VG, Gurav VJ, Ganapati R 1989. Clinical assessment of paucibacillary leprosy under multidrug therapy - three years follow-up study. Indian J Lepr 61: 344-349.
20. Reddy PK, Mohinuddin SK 1988. Pattern of relapses in paucibacillary leprosy patients treated with MDT (WHO 1982). Indian J Lepr 61: 344-349.
21. Sengupta U, Ramu G, Revankar CR et al 1984. Evaluation of standard Dharmendra lepromin. Indian J Lepr 56: 748-753.
22. Sharma RK, Shivannavar CT, Katoch K et al 1997. Microdensitometric scanning procedure for quantitative assessment of hybridization of rRNA targetting probes in leprosy. Acta Leprol 10: 213-217.
23. WHO Study Group 1982. Chemotherapy of leprosy for control programmes. Geneva: World Health Organization. Tech Rep Ser 675: 24-27.
24. WHO 1985. Report of a consultation on implementation of multidrug therapy for leprosy control. WHO/LEP/85.1. Geneva, World Health Organization.
25. WHO 1987. Report on the second co-ordinating meeting on implementation of multidrug therapy for control programmes, WHO/CDS/LEP/87.2. Geneva, World Health Organization.